Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) remains one of the most common endocrine disorder in premenopausal women with an unfavorable metabolic risk profile. Here, we investigate whether biochemical hyperandrogenism, represented by elevated serum free testosterone, resulted in an aberrant circulating microR...
Main Authors: | Anja E. Sørensen, Pernille B. Udesen, Grzegorz Maciag, Julian Geiger, Negar Saliani, Andrzej S. Januszewski, Guozhi Jiang, Ronald C. Ma, Anandwardhan A. Hardikar, Marie Louise M. Wissing, Anne Lis M. Englund, Louise T. Dalgaard |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00242/full |
Similar Items
-
Markers of hyperandrogenism in South Asians with polycystic ovary syndrome
by: WMM Boteju, et al.
Published: (2014-08-01) -
hyperandrogenism in polycystic ovary syndrome
by: malka S. Al- saadi
Published: (2006-01-01) -
Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism
by: Helena Hachul, et al.
Published: (2019-04-01) -
Hyperandrogenism syndrome: diagnostics and treatment from the position of clinical endocrinology
by: M.R. Mykytyuk, et al.
Published: (2020-11-01) -
Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
by: Marzieh Farimani Sanoee, et al.
Published: (2011-06-01)